JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $36
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $36.
JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $31 to $36.